AstraZeneca drops approval request in Switzerland

Thursday, 04. November 2021 09:50

AstraZeneca plc has withdrawn the request for approval of its COVID-19 vaccine in Switzerland, the country's authority on medicines and medical devices, Swissmedic, unveiled in a statement on Thursday.

"The company has withdrawn its application for a COVID-19 vaccine authorization that it submitted to Swissmedic in October 2020," the statement read, without providing further details.

Media reports previously signaled that AstraZeneca's potential withdrawal from the Swiss market could come amid Swissmedic's decision to recommend the use of the jab only for those aged 50 and older.

Related Links: AstraZeneca plc
Baha Breaking the News (BBN) / BU